New price proposal of Gleevec on sharp backlash

The Joint Counter Measure Council for Gleevec Pricing and Expansion of Drug Public Benefits (hereinafter called Gleevec Pricing Council: GPC), a civic organization for fighting against Norvatis' Gleevec pricing policy, responded with a harsh backlash against which Norvatis Korea proposed a new price for Gleevec, an anti-cancer drug.

The GPC claimed in the position paper that Norvatis new pri...